Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Uitbraak van hepatitis A onder MSM
jun 2017 | Hepatitis
jun 2024 | Niertransplantatie, Stamceltransplantatie, Virale infecties